Results 121 to 130 of about 26,400 (244)
Don't Sweat It: Cannabinoid CB1 Receptors Reduce Sweating in a Mouse Model
A new galvanic skin response‐based approach offers a simple method for measuring sweating in the paws of mice. This method is used to demonstrate that cannabinoid CB1 receptors reduce baseline sweating in mice, likely via inhibition of sympathetic acetylcholine release via axonal CB1 receptors.
Natalia Murataeva +3 more
wiley +1 more source
P(論文)Ductal cells were purified by Percoll centrifugation after collagenase digestion of rat submandibular glands. After centrifugation, the cells were separated into two distinct fractions.
25936 +5 more
core
Rare coexistence of sialolithiasis and actinomycosisle in the submandibular gland
Sialolithiasis is a condition characterized by the obstruction of salivary gland or its excretory duct by a calculus or sialolith. This condition provokes swelling, pain, and infection of affected gland leading to salivary ectasia and even causing the ...
Dikici, Oguzhan +3 more
core +1 more source
What's new? The overall survival of patients with salivary gland malignancies has shown limited progress. Here, the authors evaluated the impact of establishing a multidisciplinary tumor board to ensure standardized diagnostic and treatment procedures at a certified cancer center.
Nils Feldmann +3 more
wiley +1 more source
Objectives This study aimed to examine the suppressive effect of the natural antioxidant vitamin C (VC) against submandibular gland toxicity induced by copper oxide nanoparticles (CuO-NPs).
Baz, Safaa +6 more
core +1 more source
What's new? Adaptive immune responses are typically limited in pancreatic ductal adenocarcinoma, resulting in minimal efficacy of immune checkpoint inhibitors. Tumor Treating Fields (TTFields) therapy, which uses low‐intensity intermediate‐frequency electric fields to disrupt cancer cell processes, has been approved for certain cancers.
Tal Kan +21 more
wiley +1 more source
Improved Systemic Immunochemotherapy Employing an Oxaliplatin‐TLR7/8 Agonist Prodrug Strategy
A platinum(IV) prodrug is developed to systemically deliver the TLR7/8 agonist gardiquimod. Tumor‐targeting is mediated by an albumin‐binding maleimide, which limits premature complex activation. Ox‐Gardi‐Mal accumulates specifically in the tumor, where it activates the immune system.
Michael Gutmann +15 more
wiley +1 more source
ABSTRACT This study aimed to investigate the mechanism of ophiopogonin D (OD) in treating primary Sjögren's syndrome (pSS) through integrated analysis of gut microbiota and metabolomics. Non‐obese diabetic/LtJ mice, a well‐established pSS model, were used as the model group and treated with OD or hydroxychloroquine.
Fengtao Pang +3 more
wiley +1 more source
Transoral Ultrasound Diagnosed Bilateral Peritonsillar Abscess in Patient Admitted With Tonsillitis
ABSTRACT Transoral ultrasound is a valuable tool for PTA diagnostics, especially when the diagnosis is uncertain due to ambiguous findings.
Amalie Hartvig Pall Posselt +2 more
wiley +1 more source
Abstract Down syndrome (DS) is the most prevalent form of intellectual disability (ID) globally, with an incidence rate of approximately 1 in 1000 births, affecting over 5 million individuals worldwide. DS is characterized by a genetic profile that predisposes individuals to a range of medical and cognitive conditions, including ID and obesity, which ...
Mohammed Selloum +20 more
wiley +1 more source

